Statistics from Altmetric.com
Review of: Medicines and Healthcare products Regulatory Agency (MHRA) review of glucosamine-containing products.
Key learning points
Products that contain base glucosamine at 1178 mg/day or higher cannot be sold without a marketing authorisation.
Products containing less than 1178 mg/day of glucosamine will continue to be available as food supplements.
The Medicines and Healthcare products Regulatory Agency has advised that affected products should be removed from counter and dispensary shelves to avoid the inadvertent sale or supply of unauthorised medicinal products.
Products containing doses equal to or greater than 1178 mg/day of base glucosamine are now considered to be medicines and cannot be sold without marketing authorisation.1
The Medicines and Healthcare products Regulatory Agency …
Contributors: DTB Team.
Competing interests Commissioned; internally peer reviewed.